Expression and prognostic values of Id-1 and Id-3 in gastric adenocarcinoma

Journal of Surgical Research

Volumn 167, Issue 2, 2011, Pages 258-266

  Yang, Hai Yan ^a   Liu, Hao Ling ^a   Liu, Gai Yun ^b   Zhu, Hong ^a   Meng, Qing Wen ^c   Qu, Lian Dong ^c   Liu, Lian Xin ^a   Jiang, Hong Chi ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

^b Beijing GP Medical Technologies   (China)

^c INSTITUTE OF PLANT PROTECTION   (China)

Author keywords

3 year survival; clinical values; disregulation; expression; Id 1; Id 3; immunohistochemistry; prognostic; Western blotting

Indexed keywords

INHIBITOR OF DIFFERENTIATION 1; INHIBITOR OF DIFFERENTIATION 3;

ADULT; AGED; ARTICLE; HUMAN; HUMAN TISSUE; IMMUNOPATHOLOGY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; STOMACH CANCER; STOMACH TUMOR; WESTERN BLOTTING;

ADENOCARCINOMA; ADULT; AGED; CASE-CONTROL STUDIES; CELL PROLIFERATION; DISEASE PROGRESSION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INHIBITOR OF DIFFERENTIATION PROTEIN 1; INHIBITOR OF DIFFERENTIATION PROTEINS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; NEOPLASM PROTEINS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; STOMACH NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 79954610190     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2009.08.006     Document Type: Article

References (36)

1. D.M. Parkin, P. Pisani, and J. Ferlay Global cancer statistics CA Cancer J Clin 49 1999 33
2. P. Hohenberger, and S. Gretschel Gastric cancer Lancet 362 2003 305
3. Christian Prinz, Susanne Schwendy, and Petra Voland H pylori and gastric cancer: Shifting the global burden World J Gastroenterol 12 2006 5458
4. X. Sun, R. Mu, Y. Zhou, and X. Dai 1990-1992 mortality of stomach cancer in China Zhonghua Zhongliu Zazhi 24 2002 4
5. T. Hiyama, K. Haruma, and Y. Kitadai K-ras mutation in Helicobacter pylori-associated chronic gastritis in patients with and without gastric cancer Int J Cancer 97 2002 562
6. R.J. Menaker, A.A. Sharaf, and N.L. Jones Helicobacter pylori Infection and gastric cancer: Host, bug, environment, or all three? Curr Gastroenterol Rep 6 2004 429
7. S.G. Lee, B. Kim, J.H. Yook, and S.T. Oh TNF/LTA polymorphisms and risk for gastric cancer/duodenal ulcer in the Korean population Cytokine 28 2004 75
8. J. Perk, A. Iavarone, and R. Benezra Id family of helix-loop-helix proteins in cancer Nat Rev Cancer 5 2005 603
9. Z. Zebedee, and E. Hara Id proteins in cell cycle control and cellular senescence Oncogene 20 2001 8317
10. K. Gundersen, and J.P. Merlie Id-1 as a possible transcriptional mediator of muscle disuse atrophy Proc Natl Acad Sci U S A 91 1994 3647
11. I.N. Melnikova, M. Bounpheng, and G.C. Schatteman Differential biological activities of mammalian Id proteins in muscle cells Exp Cell Res 247 1999 94
12. M.T. Ling, X. Wang, and X. Zhang The multiple roles of Id-1 in cancer progression Differentiation 74 2006 481
13. I.N. Melnikova, and B.A. Christy Muscle cell differentiation is inhibited by the helix-loop-helix protein Id3 Cell Growth Differ 7 1996 1067
14. T. Tsuchiya, Y. Okaji, and N.H. Tsuno Targeting Id1 and Id3 inhibits peritoneal metastasis of gastric cancer Cancer Sci 96 2005 784
15. C.M. Simbulan-Rosenthal, A. Daher, and V. Trabosh Id3 induces a caspase-3- and -9-dependent apoptosis and mediates UVB sensitization of HPV16 E6/7 immortalized human keratinocytes Oncogene 25 2006 3649
16. C.Q. Lin, J. Singh, and K. Murata A role for Id-1 in the aggressive phenotype and steroid hormone response of human breast cancer cells Cancer Res 60 2000 1332
17. E. Kebebew, P.A. Treseler, and Q.Y. Duh The helix-loop-helix transcription factor. Id-1, is overexpressed in medullary thyroid cancer Surgery 128 2000 952
18. K. Langlands, G.A. Down, and T. Kealey Id proteins are dynamically expressed in normal epidermis and dysregulated in squamous cell carcinoma Cancer Res 60 2000 5929
19. H. Maruyama, J. Kleef, and S. Wildi Id-1 and Id-2 are overexpressed in pancreatic cancer and in dysplastic lesions in chronic pancreatitis Am J Pathol 155 1999 815
20. J.M. Arnold, S.C. Mok, and D. Purdle Decreased expression of the ID3 gene at 1p36.1 in ovarian adenocarcinomas Br J Cancer 84 2001 352
21. M. Schindl, G. Oberhuber, and A. Obermair Overexpression of Id-1 protein is a marker for unfavorable prognosis in early-stage cervical cancer Cancer Res 61 2001 5703
22. H.A. Sikder, M.K. Devlin, and S. Dunlap Id proteins in cell growth and tumorigenesis Cancer Cell 3 2003 525
23. E. Kebebew Id1 gene expression and regulation in human thyroid tissue Thyroid 15 2005 522
24. S.D. McAllister, R.T. Christian, and M.P. Horowitz Cannabidiol as a novel inhibitor of Id-1 gene expression in aggressive breast cancer cells Mol Cancer Ther 6 2007 2921
25. N. Takai, T. Miyazaki, and K. Fujisawa Id1 expression is associated with histologic grade and invasive behavior in endometrial carcinoma Cancer Lett 165 2001 185
26. A.J. Asirvatham, J.P. Carey, and J. Chaudhary ID1-, ID2-, and ID3-regulated gene expression in E2A positive or negative prostate cancer cells Prostate 67 2007 1411
27. S.D. Cummings, B. Ryu, and M.A. Samuels Id1 delays senescence of primary human melanocytes Mol Carcinog 47 2008 653
28. J.W. Wilson, R.W. Deed, and T. Inoue Expression of Id helix-loop-helix proteins in colorectal adenocarcinoma correlates with p53 expression and mitotic index Cancer Res 61 2001 8803
29. B.M. Wice, and E. Bernal-Mizrachi Glucose and other insulin secretagogues induce, rather than inhibit, expression of Id-1 and Id-3 in pancreatic islet beta cells Diabetologia 44 2001 453
30. J.M. Arnold, S.C. Mok, and D. Purdie Decreased expression of the Id3 gene at 1p36.1 in ovarian adenocarcinomas Br J Cancer 84 2001 352
31. O. Gautschi, C.G. Tepper, and P.R. Purnell Regulation of Id1 expression by SRC: Implications for targeting of the bone morphogenetic protein pathway in cancer Cancer Res 68 2008 2250
32. Q. Wang, S.W. Tsao, and S. Fu Overexpression of Id-1 in gastric adenocarcinoma: Implication for a novel diagnostic marker Anticancer Res 24 2004 881
33. S. Paget The distribution of secondary growths in cancer of the breast. 1889 Cancer Metastasis Rev 8 1989 98
34. L. Weiss Metastatic inefficiency Adv Cancer Res 54 1990 159
35. L. Weiss Cancer cell traffic from the lungs to the liver: An example of metastatic inefficiency Int J Cancer 25 1980 385
36. B. Psaila, and D. Lyden The metastatic niche: Adapting the foreign soil Nat Rev Cancer 9 2009 285